Camidge et al. [17,18] reported that 19% of ALK rearrangement positive and 62% of ALK rearrangement negative NSCLC cases exhibited an increased ALK copy number (>3 copies per cell in >40% of cells). The gene discussed is ALK; the disease is non-small cell lung carcinoma.